Open Access Opinion

Levofloxacin Based H. Pylori Eradication Therapy, should we Give it A better Consideration?

Ahmad Nabil Lotfy Hassan*

Department of Tropical Medicine & Hepatology, Faculty of Medicine, Cairo university, Egypt

Corresponding Author

Received Date: June 17, 2019;  Published Date: June 19, 2019


Helicobacter pylori (H. pylori) infection, one of the most common bacterial infections, affects approximately 50% of the world’s population [1]. H. pylori infection is a major cause of gastritis, gastric and duodenal ulcers, mucosal associated lymphoid tissue, and gastric cancer [2]. H. pylori eradication treatment has been proven to improve gastric inflammation, promote ulcer healing, and reduce the incidence of gastric cancer [3,4].

Signup for Newsletter
Scroll to Top